(Q38055249)

27 August 2017

title

Do low testosterone levels contribute to ill-health during male ageing? (English)

1 reference

27 August 2017

1 reference

Bu B Yeap

1

1 reference

27 August 2017

Andre B Araujo

series ordinal

2

1 reference

27 August 2017

Gary A Wittert

series ordinal

3

1 reference

27 August 2017

publication date

1 September 2012

1 reference

Critical Reviews in Clinical Laboratory Sciences

27 August 2017

published in

1 reference

27 August 2017

volume

49

1 reference

27 August 2017

issue

5-6

1 reference

27 August 2017

page(s)

168-182

1 reference

Sex steroids and the free hormone hypothesis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The contribution of different androgen receptor domains to receptor dimerization and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Recognizing rare disorders: aromatase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Aromatase activity and bone homeostasis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Non-classical actions of testosterone: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Clinical review: Why is androgen replacement in males controversial?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Serum testosterone assays--accuracy matters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Comparison of methods to measure low serum estradiol levels in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Standardization of hormonal assays for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Accuracy of calculated free testosterone formulae in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones in men aged 40-80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone and estradiol among older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Predictive accuracy and sources of variability in calculated free testosterone estimates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The decline of androgen levels in elderly men and its clinical and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Prevalence of symptomatic androgen deficiency in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Identification of late-onset hypogonadism in middle-aged and elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone and ill-health in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Frailty in older adults: evidence for a phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Frailty: an emerging geriatric syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Treating frailty--a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The I.A.N.A Task Force on frailty assessment of older people in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The brave new world of function-promoting anabolic therapies: testosterone and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Higher testosterone levels are associated with less loss of lean body mass in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low free testosterone predicts frailty in older men: the health in men study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone and growth hormone improve body composition and muscle performance in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Adverse events associated with testosterone administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Blood testosterone threshold for androgen deficiency symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The relationship between libido and testosterone levels in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Prevalence of sexual activity and associated factors in men aged 75 to 95 years: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The relationships between sex hormones and sexual function in middle-aged and older European men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effects of testosterone on sexual function in men: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low testosterone in men with type 2 diabetes: significance and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous hormones and carotid atherosclerosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Increased carotid atherosclerosis in andropausal middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones and progression of carotid atherosclerosis in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Association of low total testosterone levels and prevalent carotid plaques: result of the study of health in Pomerania.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones and cardiovascular disease incidence in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Serum estradiol and risk of stroke in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Lower testosterone levels predict incident stroke and transient ischemic attack in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Elevated LH predicts ischaemic heart disease events in older men: the Health in Men Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low serum testosterone and mortality in male veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low serum testosterone and mortality in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Serum testosterone but not leptin predicts mortality in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low serum testosterone and estradiol predict mortality in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Sex steroid hormone concentrations and risk of death in US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

The short-term effects of high-dose testosterone on sleep, breathing, and function in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Acute testosterone deprivation reduces insulin sensitivity in men

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Androgens and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Androgens and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Testosterone treatment and mortality in men with low testosterone levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Caveat emptor: does testosterone treatment reduce mortality in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

Associations between Testosterone Levels and Incident Prostate, Lung, and Colorectal Cancer. A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408363.2012.725461

10.3109/10408363.2012.725461

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference